Another Sindh City Becomes HIV Hotspot With Hundreds of New Cases
The Mirpurkhas district in Sindh is rapidly becoming a new epicenter for pediatric HIV cases, drawing parallels to the 2019 ...
Understanding congenital syphilis: a growing concern in South Africa
South Africa faces a significant public health challenge with a reported 1 739 congenital syphilis cases in 2023, far ...
Fijivillage3h
Journalists urged to investigate and raise awareness on HIV crisis
As HIV becomes an increasing concern in our country with over 1,000 cases recorded in the first nine months of last year, the ...
Science Daily8h
Designing antivirals for shape-shifting viruses
Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication. However, viruses are dynamic ...
Philadelphia Gay News10h
Galaei’s Black BDSM event promotes sex positivity
Galaei will be producing its inaugural Black BDSM event to recognize Black and brown community members and their ...
The Guardian Nigeria13h
How USAID freeze halted potential HIV vaccine tests in Africa— SABC
U.S. President Donald Trump's order to freeze all foreign development assistance has stunted the efforts of a South African-led HIV ...
unaids13h
How the shift in US funding is threatening both the lives of people affected by HIV and the community groups supporting them
In a joint survey by Aidsfonds, GNP+ and the Robert Carr Fund 22% of organizations reported increased experiences of discrimination, including reports of discrimination within healthcare settings, ...
Healio15h
FDA sets date for decision on twice-yearly shots to prevent HIV
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
Utah Public Radio16h
A breakthrough HIV drug was developed using Utah biochemistry research
An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...
Scientists develop new natural killer cell strategy to target HIV
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV
Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...
South African scientists were testing a promising HIV vaccine. Then came Trump’s aid cuts
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded ...